Practical diagnosis and management of dementia due to Alzheimer's disease in the primary care setting: An evidence-based approach

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 15, Issue 4, 2013, Pages

  Geldmacher, David S ^a   Kerwin, Diana R ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; ESTROGEN; GALANTAMINE; GINKGO BILOBA EXTRACT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEMANTINE; MONOAMINE OXIDASE B INHIBITOR; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; RIVASTIGMINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ALZHEIMER DISEASE; ARTICLE; BEHAVIOR THERAPY; COGNITION; CONSENSUS SEQUENCE; DAILY LIFE ACTIVITY; DEMENTIA; DEPRESSION; DSM-IV; EVIDENCE BASED MEDICINE; GENERAL PRACTITIONER; HEALTH PROGRAM; HUMAN; INCIDENCE; MEDICAL SOCIETY; MUSIC THERAPY; PATIENT CARE; PRACTICE GUIDELINE; PREVALENCE; PRIMARY MEDICAL CARE; PSYCHOSIS; RISK FACTOR; SOCIAL CARE; SOCIAL WORK; SYMPTOMATOLOGY;

EID: 84884246730     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.12r01474     Document Type: Article

References (70)

1. Alzheimer's Association. 2012 Alzheimer's disease facts and figures. Alzheimer's Association Web site. www.alz.org/downloads/facts_figures_2012.pdf. Accessed July 26, 2012.
2. Doody RS, Stevens JC, Beck C, et al. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56(9):1154-1166. PubMed doi:10.1212/WNL.56.9.1154 Show Abstract
3. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):263-269. PubMed doi:10.1016/j.jalz.2011.03.005 Show Abstract
4. Petersen RC, Stevens JC, Ganguli M, et al. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56(9):1133-1142. PubMed doi:10.1212/WNL.56.9.1133 Show Abstract
5. Rabins PV, Blacker D, Rovner BW, et al; APA Work Group on Alzheimer's Disease and other Dementias; Steering Committee on Practice Guidelines. American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias, 2nd edition. Am J Psychiatry. 2007;164(suppl 12):5-56. PubMed Show Abstract
6. US Department of Health and Human Services. National Plan to Address Alzheimer's Disease. US Department of Health and Human Services. http://aspe.hhs.gov/daltcp/napa/NatlPlan.shtml. Accessed July 26, 2012.
7. AGS Clinical Practice Committee. Guidelines abstracted from the American Academy of Neurology's Dementia Guidelines for Early Detection, Diagnosis, and Management of Dementia. J Am Geriatr Soc. 2003;51(6):869-873. PubMed doi:10.1046/j.1365-2389.2003.51272.x Show Abstract
8. Cordell CB, Borson S, Boustani M, et al; Medicare Detection of Cognitive Impairment Workgroup. Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare annual wellness visit in a primary care setting. Alzheimers Dement. 2013;9(2):141-150. PubMed doi:10.1016/j.jalz.2012.09.011 Show Abstract
9. Hughes C. Medicare annual wellness visits: don't forget the health risk assessment. Fam Pract Manag. 2012;19(2):11-14. PubMed Show Abstract
10. Boise L, Camicioli R, Morgan DL, et al. Diagnosing dementia: perspectives of primary care physicians. Gerontologist. 1999;39(4):457-464. PubMed doi:10.1093/geront/39.4.457 Show Abstract
11. Turner S, Iliffe S, Downs M, et al. General practitioners' knowledge, confidence and attitudes in the diagnosis and management of dementia. Age Ageing. 2004;33(5):461-467. PubMed doi:10.1093/ageing/afh140 Show Abstract
12. Hinton L, Franz CE, Reddy G, et al. Practice constraints, behavioral problems, and dementia care: primary care physicians' perspectives. J Gen Intern Med. 2007;22(11):1487-1492. PubMed doi:10.1007/s11606-007-0317-y Show Abstract
13. Adams WL, McIlvain HE, Geske JA, et al. Physicians' perspectives on caring for cognitively impaired elders. Gerontologist. 2005;45(2):231-239. PubMed doi:10.1093/geront/45.2.231 Show Abstract
14. Apesoa-Varano EC, Barker JC, Hinton L. Curing and caring: the work of primary care physicians with dementia patients. Qual Health Res. 2011;21(11):1469-1483. PubMed doi:10.1177/1049732311412788 Show Abstract
15. Boustani M, Sachs G, Callahan CM. Can primary care meet the biopsychosocial needs of older adults with dementia? J Gen Intern Med. 2007;22(11):1625-1627. PubMed doi:10.1007/s11606-007-0386-y Show Abstract
16. Bass DM, Clark PA, Looman WJ, et al. The Cleveland Alzheimer's managed care demonstration: outcomes after 12 months of implementation. Gerontologist. 2003;43(1):73-85. PubMed doi:10.1093/geront/43.1.73 Show Abstract
17. Boustani MA, Sachs GA, Alder CA, et al. Implementing innovative models of dementia care: the Healthy Aging Brain Center. Aging Ment Health. 2011;15(1):13-22. PubMed doi:10.1080/13607863.2010.496445 Show Abstract
18. Burns R, Nichols LO, Martindale-Adams J, et al. Primary care interventions for dementia caregivers: 2-year outcomes from the REACH study. Gerontologist. 2003;43(4):547-555. PubMed doi:10.1093/geront/43.4.547 Show Abstract
19. Callahan CM, Boustani MA, Unverzagt FW, et al. Effectiveness of collaborative care for older adults with Alzheimer disease in primary care: a randomized controlled trial. JAMA. 2006;295(18):2148-2157. PubMed doi:10.1001/jama.295.18.2148 Show Abstract
20. Feil DG, MacLean C, Sultzer D. Quality indicators for the care of dementia in vulnerable elders. J Am Geriatr Soc. 2007;55(suppl 2):S293-S301. PubMed doi:10.1111/j.1532-5415.2007.01335.x Show Abstract
21. US Preventive Services Task Force. Screening for dementia: recommendations and rationale. 2003. 03-520A. http://www.uspreventiveservicestaskforce.org/3rduspstf/dementia/dementrr.htm. Accessed May 8, 2013.
22. Qaseem A, Snow V, Cross JT Jr, et al; American College of Physicians/American Academy of Family Physicians Panel on Dementia. Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med. 2008;148(5):370-378. PubMed doi:10.7326/0003-4819-148-5-200803040-00008 Show Abstract
23. American Geriatrics Society. A Guide to the Management of Psychotic Disorders and Neuropsychiatric Symptoms of Dementia in Older Adults (April 2011). American Geriatrics Society Web site. http://dementia.americangeriatrics.org/AGSGeriPsychConsult.pdf. Accessed January 28, 2012.
24. Dubinsky RM, Stein AC, Lyons K. Practice parameter: risk of driving and Alzheimer's disease (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2000;54(12):2205-2211. PubMed doi:10.1212/WNL.54.12.2205 Show Abstract
25. Lyketsos CG, Colenda CC, Beck C, et al; Task Force of American Association for Geriatric Psychiatry. Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. Am J Geriatr Psychiatry. 2006;14(7):561-572. PubMed doi:10.1097/01.JGP.0000221334.65330.55 Show Abstract
26. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter for diagnosis and evaluation of dementia (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 1994;44(11):2203-2206. PubMed doi:10.1212/WNL.44.11.2203 Show Abstract
27. Iverson DJ, Gronseth GS, Reger MA, et al; Quality Standards Subcomittee of the American Academy of Neurology. Practice parameter update: evaluation and management of driving risk in dementia: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010;74(16):1316-1324. PubMed doi:10.1212/WNL.0b013e3181da3b0f Show Abstract
28. Alzheimer's Association. 2011 Alzheimer's disease facts and figures. Alzheimer's Association Web site. http://www.alz.org/downloads/Facts_Figures_2011.pdf. Accessed May 8, 2013.
29. Hebert LE, Scherr PA, Bienias JL, et al. Alzheimer's disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003;60(8):1119-1122. PubMed doi:10.1001/archneur.60.8.1119 Show Abstract
30. Borson S, Scanlan J, Brush M, et al. The Mini-Cog: a cognitive "vital signs" measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry. 2000;15(11):1021-1027. PubMed doi:10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6 Show Abstract
31. Brodaty H, Pond D, Kemp NM, et al. The GPCOG: a new screening test for dementia designed for general practice. J Am Geriatr Soc. 2002;50(3):530-534. PubMed doi:10.1046/j.1532-5415.2002.50122.x Show Abstract
32. Buschke H, Kuslansky G, Katz M, et al. Screening for dementia with the Memory Impairment Screen. Neurology. 1999;52(2):231-238. PubMed doi:10.1212/WNL.52.2.231 Show Abstract
33. Cullen B, O'Neill B, Evans JJ, et al. A review of screening tests for cognitive impairment. J Neurol Neurosurg Psychiatry. 2007;78(8):790-799. PubMed doi:10.1136/jnnp.2006.095414 Show Abstract
34. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198. PubMed doi:10.1016/0022-3956(75)90026-6 Show Abstract
35. Kuslansky G. The Mini-Cog compares well with longer screening tests for detecting dementia in older people. Evid Based Ment Health. 2004;7(2):38. PubMed doi:10.1136/ebmh.7.2.38 Show Abstract
36. Kuslansky G, Buschke H, Katz M, et al. Screening for Alzheimer's disease: the Memory Impairment Screen versus the conventional three-word memory test. J Am Geriatr Soc. 2002;50(6):1086-1091. PubMed doi:10.1046/j.1532-5415.2002.50265.x Show Abstract
37. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc. 1975;23(10):433-441. PubMed Show Abstract
38. Tariq SH, Tumosa N, Chibnall JT, et al. Comparison of the Saint Louis University Mental Status Examination and the Mini-Mental State Examination for detecting dementia and mild neurocognitive disorder: a pilot study. Am J Geriatr Psychiatry. 2006;14(11):900-910. PubMed doi:10.1097/01.JGP.0000221510.33817.86 Show Abstract
39. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-699. PubMed doi:10.1111/j.1532-5415.2005.53221.x Show Abstract
40. Galvin JE, Roe CM, Powlishta KK, et al. The AD8: a brief informant interview to detect dementia. Neurology. 2005;65(4):559-564. PubMed doi:10.1212/01.wnl.0000172958.95282.2a Show Abstract
41. Villars H, Oustric S, Andrieu S, et al. The primary care physician and Alzheimer's disease: an international position paper. J Nutr Health Aging. 2010;14(2):110-120. PubMed doi:10.1007/s12603-010-0022-0 Show Abstract
42. Clarfield AM. The decreasing prevalence of reversible dementias: an updated meta-analysis. Arch Intern Med. 2003;163(18):2219-2229. PubMed doi:10.1001/archinte.163.18.2219 Show Abstract
43. Muangpaisan W, Petcharat C, Srinonprasert V. Prevalence of potentially reversible conditions in dementia and mild cognitive impairment in a geriatric clinic. Geriatr Gerontol Int. 2012;12(1):59-64. PubMed doi:10.1111/j.1447-0594.2011.00728.x Show Abstract
44. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944. doi:10.1212/WNL.34.7.939 PubMed
45. Jack CR Jr, Albert MS, Knopman DS, et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):257-262. PubMed doi:10.1016/j.jalz.2011.03.004 Show Abstract
46. Dubois B, Feldman HH, Jacova C, et al. Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol. 2010;9(11):1118-1127. PubMed doi:10.1016/S1474-4422(10)70223-4 Show Abstract
47. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):270-279. PubMed doi:10.1016/j.jalz.2011.03.008 Show Abstract
48. US Food and Drug Administration Web site. FDA press release 2012. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm299678.htm. Accessed July 26, 2012.
49. Johnson KA, Minoshima S, Bohnen NI, et al. Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association. Alzheimers Dement. 2013;9(1):e1-e16. PubMed doi:10.1016/j.jalz.2013.01.002 Show Abstract
50. Exelon [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2006.
51. Exelon Patch [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2010.
52. Razadyne-Razadyne ER [package insert]. Titusville, NJ: Ortho-McNeil-Janssen Pharmaceuticals, Inc; 2011.
53. Namenda [package insert]. St. Louis, MO: Forest Pharmaceuticals, Inc; 2007.
54. Aricept [package insert]. Woodcliff Lake, NJ: Eisai Inc; 2010.
55. Vellas B, Coley N, Ousset PJ, et al; GuidAge Study Group. Long-term use of standardised ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol. 2012;11(10):851-859. PubMed doi:10.1016/S1474-4422(12)70206-5 Show Abstract
56. Mulnard RA, Cotman CW, Kawas C, et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA. 2000;283(8):1007-1015. PubMed doi:10.1001/jama.283.8.1007 Show Abstract
57. Jaturapatporn D, Isaac MG, McCleery J, et al. Aspirin, steroidal and nonsteroidal anti-inflammatory drugs for the treatment of Alzheimer's disease. Cochrane Database Syst Rev. 2012;2:CD006378. PubMed Show Abstract
58. Feldman HH, Doody RS, Kivipelto M, et al; LEADe Investigators. Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe. Neurology. 2010;74(12):956-964. PubMed doi:10.1212/WNL.0b013e3181d6476a Show Abstract
59. Quinn JF, Raman R, Thomas RG, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA. 2010;304(17):1903-1911. PubMed doi:10.1001/jama.2010.1510 Show Abstract
60. Gauthier S, Molinuevo JL. Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer's disease. Alzheimers Dement. 2013;9(3):326-331. PubMed Show Abstract
61. Raina P, Santaguida P, Ismaila A, et al. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Intern Med. 2008;148(5):379-397. PubMed doi:10.7326/0003-4819-148-5-200803040-00009 Show Abstract
62. Geldmacher DS, Provenzano G, McRae T, et al. Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease. J Am Geriatr Soc. 2003;51(7):937-944. PubMed doi:10.1046/j.1365-2389.2003.51306.x Show Abstract
63. Lopez OL, Becker JT, Wisniewski S, et al. Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2002;72(3):310-314. PubMed doi:10.1136/jnnp.72.3.310 Show Abstract
64. Mittelman MS, Ferris SH, Shulman E, et al. A family intervention to delay nursing home placement of patients with Alzheimer disease: a randomized controlled trial. JAMA. 1996;276(21):1725-1731. PubMed doi:10.1001/jama.1996.03540210033030 Show Abstract
65. Mittelman MS, Haley WE, Clay OJ, et al. Improving caregiver well-being delays nursing home placement of patients with Alzheimer disease. Neurology. 2006;67(9):1592-1599. PubMed doi:10.1212/01.wnl.0000242727.81172.91 Show Abstract
66. Vickrey BG, Mittman BS, Connor KI, et al. The effect of a disease management intervention on quality and outcomes of dementia care: a randomized, controlled trial. Ann Intern Med. 2006;145(10):713-726. PubMed doi:10.7326/0003-4819-145-10-200611210-00004 Show Abstract
67. Cherry DL, Vickrey BG, Schwankovsky L, et al. Interventions to improve quality of care: the Kaiser Permanente-Alzheimer's Association Dementia Care Project. Am J Manag Care. 2004;10(8):553-560. PubMed Show Abstract
68. Cherry DL, Hahn C, Vickrey BG. Educating primary care physicians in the management of Alzheimer's disease: using practice guidelines to set quality benchmarks. Int Psychogeriatr. 2009;21(suppl 1):S44-S52. PubMed doi:10.1017/S1041610209008692 Show Abstract
69. Reuben DB, Roth C, Kamberg C, et al. Restructuring primary care practices to manage geriatric syndromes: the ACOVE-2 intervention. J Am Geriatr Soc. 2003;51(12):1787-1793. PubMed doi:10.1046/j.1532-5415.2003.51565.x Show Abstract
70. Guerriero Austrom M, Damush TM, Hartwell CW, et al. Development and implementation of nonpharmacologic protocols for the management of patients with Alzheimer's disease and their families in a multiracial primary care setting. Gerontologist. 2004;44(4):548-553. PubMed doi:10.1093/geront/44.4.548 Show Abstract